Andrew Cittadine - Jun 1, 2021 Form 4 Insider Report for Monopar Therapeutics (MNPR)

Role
Chief Operating Officer
Signature
/s/ Kim R. Tsuchimoto, Attorney-in-Fact
Stock symbol
MNPR
Transactions as of
Jun 1, 2021
Transactions value $
$0
Form type
4
Date filed
6/2/2021, 04:11 PM
Next filing
Jul 2, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNPR Stock Options Award $0 +70K $0.00 70K Jun 1, 2021 Common Stock 70K $5.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vest 6/48ths on November 30, 2021 and 1/48th monthly on the last day of each month thereafter.